Is Ipca Laboratories Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Ipca Laboratories Limited pays dividends. Last time was Tuesday 10th of September 2024 where the investors holding the stock on Tuesday 6th of August 2024 were paid INR2 per share. Over the last 42 times between 1999 and 2024, Ipca Laboratories Limited has paid INR135.9 with an average of INR3.24 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Ipca Laboratories Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR467.52, you would have made a profit of INR955.38 per share or 204.35%
Yes, the average daily trading liquidity for Ipca Laboratories Limited is INR555 361 thousand. You should therefore be able to get in and out of your positions relatively fast.
Ipca Laboratories Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.47, the company's ability to pay off the debt is normal. Ipca Laboratories Limited has a good net profit margin of 7.10% and should have high tolerances against inflation.
We have calculated the inflation risk for Ipca Laboratories Limited to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.